Download PDF
Kinder- und Jugendmedizin 2016; 16(02): 98-107
DOI: 10.1055/s-0037-1616313
Dermatologie
Schattauer GmbH

Kutane Lyme-Borreliose bei Kindern und Jugendlichen

Cutaneous lyme borreliosis in children and adolescents
H. Hofmann
1   Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein, Technische Universität München
,
H.-I. Huppertz
2   Prof.-Hess-Kinderklinik und Klinik für Pädiatrische Intensivmedizin, Bremen
› Author Affiliations
Further Information

Publication History

Eingereicht am: 15 December 2015

angenommen am: 18 December 2015

Publication Date:
11 January 2018 (online)

    Permissions and Reprints

Zusammenfassung

Die Lyme-Borreliose, übertragen durch die Zecke Ixodes ricinus und hervorgerufen durch die Spirochäte Borrelia burgdorferi, tritt in fast 90 % der Fälle mit Hauterscheinungen auf, dem Erythema migrans, manchmal auch multilokulär, dem Borrelien-Lymphozytom und der seltenen Acrodermatitis chronica atrophicans. Das typische Erythema migrans bedarf keiner Laborbestätigung, sondern wird sofort antibiotisch behandelt: bis 8 Jahre mit Amoxycillin, danach mit Doxycyclin. Die anderen Manifestationen bedürfen der serologischen Bestätigung. Die beste Prophylaxe ist die zügige Entfernung anheftender Zecken.

Summary

Manifestations of Lyme borreliosis, transmitted by the tick Ixodes ricinus and caused by the spirochete Borrelia burgdorferi, are cutaneous in nearly 90 % of cases as erythema migrans, sometimes multilocular, borrelial lymphocytoma and the rare acrodermatitis chronica atrophicans. Typical erythema migrans should not be confirmed by serology, but treated immediately: till 8 years of age with amoxicillin, at older ages with doxycycline. All other manifestations should be confirmed by serology. Best prophylaxis is by early removal of attached ticks.

Schlüsselwörter

Borrelia burgdorferi-Infektion - Erythema migrans - multiple Erythemata migrantia - Acrodermatitis chronica atrophicans

Keywords

Borrelia burgdorferi infection - Erythema migrans - multiple erythemata migrantia - acrodermatitis chronica atrophicans
 

  • Literatur

  • 1 Arnez M, Pleterski-Rigler D, Luznik-Bufon T. et al. Solitary erythema migrans in children: comparison of treatment with azithromycin and phenoxymethylpenicillin. Wien Klin Wochenschr 2002; 114: 498-504.
    PubMedGoogle Scholar
  • 2 Arnez M. Antibiotic treatment of children with erythema migrans. Clin Infect Dis 2007; 44: 1133-1134.
    CrossrefPubMedGoogle Scholar
  • 3 Auwaerter PG, Bakken JS, Dattwyler RJ. et al. Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis 2011; 11: 713-719.
    CrossrefPubMedGoogle Scholar
  • 4 Andres C, Ziai M, Bruckbauer H. et al. Acrodermatitis chronica atrophicans in two children. Int J Dermatol 2010; 49: 180-183.
    CrossrefPubMedGoogle Scholar
  • 5 Belloni B, Andres C, Ring J. et al. Case report: 5-year-old with borrelial lymphocytoma. MMW Fortschr Med 2011; 153: 40.
    PubMedGoogle Scholar
  • 6 Benedix F, Weide B, Broekaert S, Metzler G. et al. Early disseminated borreliosis with multiple erythema migrans and elevated liver enzymes: case report and literature review. Acta Derm Venereol 2007; 87: 418-421.
    CrossrefPubMedGoogle Scholar
  • 7 Bennet L, Danell S, Berglund J. Clinical outcome of erythema migrans after treatment with phenoxymethyl penicillin. Scand J Infect Dis 2003; 35: 129-131.
    CrossrefPubMedGoogle Scholar
  • 8 Berglund J. Natural history and long-term consequences of Lyme disease in children. Curr Opin Infect Dis 1999; 12: 265-269.
    CrossrefPubMedGoogle Scholar
  • 9 Berglund J, Eitrem R, Ornstein K. et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995; 333: 1319-1327.
    CrossrefPubMedGoogle Scholar
  • 10 Biner B, Oner N, Celtik C. et al. Ceftriaxone-associated biliary pseudolithiasis in children. J Clin Ultrasound 2006; 34: 217-222.
    CrossrefPubMedGoogle Scholar
  • 11 Brettschneider S, Bruckbauer H, Klugbauer N, Hofmann H. Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol 1998; 36: 2658-2665.
    PubMedGoogle Scholar
  • 12 Brzonova I, Wollenberg A, Prinz JC. Acrodermatitis chronica atrophicans affecting all four limbs in an 11-year-old girl. Br J Dermatol 2002; 147: 375-378.
    CrossrefPubMedGoogle Scholar
  • 13 Christen HJ, Hanefeld F. Lyme-Borreliose im Kindesalter. Monatsschr Kinderheilkd 1993; 141: 513-526.
    PubMedGoogle Scholar
  • 14 Dehnert M, Fingerle V, Klier C. et al. Seropositivity of Lyme Borreliosis and Associated Risk Factors: A Population-Based Study in Children and Adolescents in Germany (KiGGS). PLoS ONE 2012; 7: e41321 doi: (PMID: 10.1371.)
    CrossrefPubMedGoogle Scholar
  • 15 Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics 2002; 109: 1173-1177.
    CrossrefPubMedGoogle Scholar
  • 16 Glatz M, Resinger A, Semmelweis K. et al. Clinical spectrum of skin manifestations of Lyme borreliosis in 204 children in Austria. Acta Derm Venereol 2015; 95: 565-571.
    CrossrefPubMedGoogle Scholar
  • 17 Hofmann H. Lyme-Borreliose. Kutane Manifestationen. Hautarzt 2005; 56: 783-795.
    CrossrefPubMedGoogle Scholar
  • 18 Hofmann H. Variabilität der Kutanen Lyme-Borreliose Diagnostik und Therapie. Hautarzt 2012; 63: 381-389.
    CrossrefPubMedGoogle Scholar
  • 19 Huppertz HI, Karch H, Suschke HJ. et al. Lyme arthritis in European children and adolescents. Arthritis Rheum 1995; 38: 361-368.
    CrossrefPubMedGoogle Scholar
  • 20 Huppertz HI, Böhme M, Standaert SM. et al. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999; 18: 697-703.
    CrossrefPubMedGoogle Scholar
  • 21 Huppertz HI, Bartmann P, Heininger U. et al. Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German. Academy for Pediatrics and Adolescent Health Eur J Pediatr 2012; 1171: 1619-1624.
    Google Scholar
  • 22 Nizic T, Velikanje E, Ružic- Sabljic E. et al. Solitary erythema migrans in children: comparison of treatment with clarithromycin and amoxicillin. Wien Klin Wochenschr 2012; 124: 427-433.
    CrossrefPubMedGoogle Scholar
  • 23 Prinz JC, Kutasi Z, Weisenssel P. et al. „Borrelia-associated early-onset morphea“: A particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. J Am Acad Dermatol 2009; 60: 248-255.
    CrossrefPubMedGoogle Scholar
  • 24 Regelin N, Montaruli E. Images in clinical medicine. Disseminated Lyme disease. N Engl J Med 2015; 372: 2136.
    CrossrefPubMedGoogle Scholar
  • 25 Robert Koch-Institut. Seroprävalenz der Lyme-borreliose bei Kindern und Jugendlichen in Deutschland. Epidemiol Bull 2012; 14: 113-120.
    Google Scholar
  • 26 Salazar JC, Gerber MA, Goff CW. Long-term outcome of Lyme disease in children given early treatment. J Pediatr 1993; 122: 591-593.
    CrossrefPubMedGoogle Scholar
  • 27 Shapiro ED, Seltzer EG. Lyme disease in children. Semin Neurol 1997; 17: 39-44.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Wilske B. Lyme Borreliose, MIQ 12, Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. München: Urban und Fischer; 2000
    Google Scholar
  • 29 Wilking H, Fingerle V, Klier C. et al Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011. Emerg Infect Dis 2015; 21: 107-110.
    CrossrefPubMedGoogle Scholar